View additional details on conference website

Cancer-associated thrombosis (CAT) is common, complex, and easy to miss, especially when time is short and treatments carry competing risks. This one-hour webinar features a multidisciplinary panel discussing practical strategies to assess risk and educate your patients .

More details can be found on the event website.

SAVE THE DATE - THORACS
Thoracic Rare Cancer Symposium - click here to view program and to register.

COURSE DESCRIPTION

The Ottawa Hospital and the University of Ottawa are proud to offer the inaugural Thoracic Rare Cancers Symposium (THORACS), to take place at the National Arts Centre, Ottawa on Friday, October 3, 2025. This one day Symposium, preceded by a dinner and opening plenary presentation on the Thursday evening, has been designed to provide thoracic cancer specialists a unique opportunity to come together and discuss the current state of diagnosis and management of rare thoracic cancers. With the advance of molecular diagnostics, an increasing number of rare lung cancers are being identified (e.g. Her2, SMARCA4, NTRK, NRG1, EGFR exon20 etc) in addition to the more widely studied variants (e.g. EGFR, ALK, Ret etc).



Through lectures, case-based discussions and workshops, participants will be able to understand novel diagnostic and therapeutic options for these rare cancers. Put together by an outstanding organizing committee including leading experts from across Canada and the USA, this symposium promises to be an annual 'must do' event in the educational calendar for thoracic cancers.




OVERALL LEARNING OBJECTIVES

At the end of this symposium, participants should be able to:

• Describe the state of the field in treatments for rare subtypes of lung cancer characterized by driver mutations or fusions and understand the oncogenic mechanism of these rare changes.
  
• Identify future targets and treatments currently in development.
  
• Discuss the role of liquid biopsy and NGS testing in the treatment of molecular subtypes of lung cancer.
  
• Discuss the challenges and possible solutions for research into rare subtypes of lung cancer. 
  


Questions? Please contact cpd@uottawa.ca

More information can be found on the congress website.

For more information, please visit the conference website.

Additional details can be found on the conference website.

The CAMO 2025 Symposium will explore the theme Global Oncology and Challenges in Cancer Care, with a particular focus on bidirectional learning—connecting insights from international cancer care with the challenges faced in North American settings. The session will highlight both global and local innovations, emphasizing strategies to improve access and outcomes for underserved populations.

Co-chaired by representatives from CAMO and WINC-ALINC, Dr. Scott Berry, Dr. Stephen Welch and Dr. Christine Brezden-Masley, the symposium will underscore the value of collaboration in addressing systemic disparities in cancer care both at home and around the world.

Program - click here | Registration - click here

This year's theme will shine a spotlight on "Breaking Boundaries: Innovations in Gynecologic Oncology and Insights into Rare Gynecologic Tumours." Explore synthesized updates around the evolving therapeutic landscape in gynecologic oncology. Uncover the latest clinical research into rare tumours, explore the role of AI in pathology and multidisciplinary cancer care, and discover innovations in radiation oncology delivery.

Taking a multidisciplinary approach, updates will be shared across gynecologic oncology, surgery, and pathology. Save with early bird registration until October 28.

For additional details, please visit the conference website.

More information can be found on the congress website.